Cargando…
Biomarkers of ketamine’s antidepressant effect: a clinical review of genetics, functional connectivity, and neurophysiology
Major depressive disorder (MDD) is one of the leading causes of morbidity and all-cause mortality (including suicide) worldwide, and, unfortunately, first-line monoaminergic antidepressants and evidence-based psychotherapies are not effective for all patients. Subanesthetic doses of the N-methyl-D-a...
Autores principales: | Alario, Alexandra A., Niciu, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186113/ https://www.ncbi.nlm.nih.gov/pubmed/34159281 http://dx.doi.org/10.1177/24705470211014210 |
Ejemplares similares
-
(Es)Ketamine for Suicidal Ideation and Behavior: Clinical Efficacy
por: Alario, Alexandra A., et al.
Publicado: (2022) -
Immunoregulation and antidepressant effect of ketamine
por: Zhang, Nan, et al.
Publicado: (2021) -
Neurophysiological Correlates and Differential Drug Response in
Subjects With a Family History of an Alcohol Use Disorder
por: Comstock, Sage M., et al.
Publicado: (2019) -
Ketamine Alters Functional Plasticity of Astroglia: An Implication for Antidepressant Effect
por: Stenovec, Matjaž
Publicado: (2021) -
Functional connectivity of the amygdala and the antidepressant and antisuicidal effects of repeated ketamine infusions in major depressive disorder
por: Liu, Haiyan, et al.
Publicado: (2023)